ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.778,06
0,38%
S&P 500
5.311,09
0,15%
Dow Jones
39.960,89
-0,11%
Euro vs US Dollar
1,08625
-0,11%
Bitcoin
66.963,79
1,21%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL)

  7. Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL) News

PXSL

Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL)

Pharmaxis Limited - Sponsored Adr (Australia) (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PXSL
DatumZeitQuelleÜberschriftSymbolFirma
22/07/200912h04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
13/07/200912h49Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
13/07/200901h22PR Newswire (US)Pharmaxis to Voluntarily De-List from NasdaqNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/200914h28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/200914h28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/200902h12PR Newswire (US)Pharmaxis Closes Share Purchase PlanNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
19/06/200914h56Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
16/06/200912h03Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
16/06/200903h11PR Newswire (US)Phase 3 Cystic Fibrosis Trial Results Presented at European ConferenceNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/06/200912h00Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/06/200902h19PR Newswire (US)Pharmaxis Announces Placement of $47 Million and Share Purchase PlanNASDAQ:PXSL
14/05/200912h04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
14/05/200901h33PR Newswire (US)U.S. FDA Accepts Aridol(TM) New Drug Application for ReviewNASDAQ:PXSL
04/05/200912h05Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/05/200910h02PR Newswire (US)Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis TrialNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
09/04/200912h03Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
07/04/200912h02Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
07/04/200901h02PR Newswire (US)New Pharmaxis Board AppointmentNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
06/04/200909h52PR Newswire (US)Pharmaxis Investor Conference CallNASDAQ:PXSL
01/04/200912h06Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
01/04/200900h58PR Newswire (US)Pharmaxis Announces Milestone in Phase III Trial for Cystic FibrosisNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
12/03/200911h04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
11/03/200907h10PR Newswire (US)Pharmaxis Appoints French Distributor for Aridol(TM)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
03/03/200915h14PR Newswire (US)Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)NASDAQ:PXSL
02/03/200912h12Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
01/03/200923h41PR Newswire (US)Pharmaxis Announces New Drug Application Submission for Aridol(TM)NASDAQ:PXSL
18/02/200912h09Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
17/02/200914h22Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
17/02/200902h04PR Newswire (US)Pharmaxis Builds Senior Management TeamNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
06/02/200912h05Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
 Showing the most relevant articles for your search:NASDAQ:PXSL

Kürzlich von Ihnen besucht

LSE
FM89
Atlas 2023-1 61
EU
3LOR
Graniteshares 3x Long Lo...
ASX
A2BCD
A2B Australia
EU
GRF5P
Euronext Green Planet Fr...
COIN
MDAUST
Moeda Loyalty Points
NASDAQ
FSULX
Fidelity Advisor Sustain...
NASDAQ
IVIL
Ivillage
LSE
91ID
Natwest Grp11%
BMF
ICFK24
ICFK24 - Maio 2024
ASX
AU000000STO6-AUD
AMEX
IDUB
Aptus International Enha...
BOV
GFSA11F
GAFISA ON
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten